-
Study aim
-
Comparison of efficiency and side effects of Adenosine versus Verapamil in treatment of Paroxysmal Supraventricular Tachycardia (PSVT)
-
Design
-
This study was designed as a single-blind clinical trial with a sample size of 180 patients with Paroxysmal Supraventricular Tachycardia (PSVT). Patients were randomly divided into control and intervention groupsWITH using sealed envelops receiving adenosine and verapamil using sealed envelopes.
-
Settings and conduct
-
Patients with Paroxysmal Supraventricular Tachycardia (PSVT) aged between 18 and 50 years were enrolled the study. exclusion critrea were History of Calcium blocker usage, history of Adenosine blocker agents usages, Brain hypo-perfusion, abnormal psychological state, pulmonary edema, pregnancy, history of Asthma, hypotension ,cardiogenic shock, heart failure, Wolff Parkinson White syndrome (WPW).
-
Participants/Inclusion and exclusion criteria
-
Patients with Paroxysmal Supraventricular Tachycardia (PSVT) aged between 18 and 50 years were enrolled the study. exclusion critrea were History of Calcium channel blocker usage, history of Adenosine blocker agents usages, Brain hypo-perfusion, abnormal psychological state, pulmonary edema, pregnancy, history of Asthma, hypotension ,cardiogenic shock, heart failure, Wolff Parkinson White syndrome (WPW).
-
Intervention groups
-
Intervention group: 6 mg adenosine intravenous push in patients with Paroxysmal Supraventricular Tachycardia (PSVT)
control group: 2.5 mg verapamil in patients with psvt rhythm
-
Main outcome variables
-
Rhythm conversion to normal sinuous